Tamsulosin

# tamsulosin ## Overview - **Classification**: Alpha1-adrenergic blocker - **Mechanism**: Selectively blocks alpha1A and alpha1B adrenergic receptors in the prostate, prostatic capsule, bladder neck, and prostatic urethra, leading to relaxation of smooth muscle and improved urine flow. ## Primary Indications 1. **Benign Prostatic Hyperplasia (BPH)** - Treatment of signs and symptoms. 2. **Off-label use for Ureteral Calculi (Kidney Stones)** - Facilitate passage of stones. ## Adult Dosing ### Standard Dosing **Benign Prostatic Hyperplasia (BPH)** - **Dose**: **0.4 mg** - **Frequency**: Once daily - **Route**: Oral - **Administration**: Approximately 30 minutes after the same meal each day. **Ureteral Calculi** (Off-label) - **Dose**: **0.4 mg** - **Frequency**: Once daily - **Route**: Oral - **Duration**: Typically up to 4 weeks, or until stone passage. ### Dose Adjustments - **Renal Impairment**: No dosage adjustment needed for mild to moderate impairment. Use with caution in severe impairment (CrCl < 10 mL/min). - **Hepatic Impairment**: No dosage adjustment needed for mild to moderate impairment. Not studied in severe impairment; use with caution. - **Elderly Patients**: No specific dose adjustment required. ## Pediatric Dosing - Tamsulosin is **not indicated** for pediatric patients. - Safety and efficacy have not been established in pediatric patients. ### Neonates (0-28 days) - No established dosing. - **Contraindicated**. ### Infants (1-12 months) - No established dosing. - **Contraindicated**. ### Children (1-12 years) - No established dosing. - **Contraindicated**. ### Adolescents (13-18 years) - No established dosing. - **Contraindicated**. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to tamsulosin or any component. - **Absolute**: History of orthostatic hypotension. - **Absolute**: Coadministration with strong CYP3A4 inhibitors (e.g., ketoconazole) in CYP2D6 poor metabolizers. ### Common Adverse Effects - **Common (1-10%)**: Dizziness, orthostatic hypotension, ejaculatory dysfunction (e.g., retrograde ejaculation), rhinitis, abnormal ejaculation. - **Serious but Rare**: Priapism (prolonged erection), Intraoperative Floppy Iris Syndrome (IFIS) during cataract/glaucoma surgery, severe allergic reactions (e.g., angioedema). ### Key Drug Interactions - **Strong CYP3A4 inhibitors (e.g., ketoconazole)**: Increased tamsulosin exposure. Avoid coadministration, especially in CYP2D6 poor metabolizers. - **Strong CYP2D6 inhibitors (e.g., paroxetine)**: Increased tamsulosin exposure. Use with caution. - **PDE-5 inhibitors (e.g., sildenafil, tadalafil)**: Risk of symptomatic hypotension due to additive vasodilatory effects. Use with caution, start PDE-5 inhibitor at lowest dose. - **Alpha-adrenergic blockers (e.g., prazosin)**: Potential for additive hypotensive effects. Avoid coadministration. ## Monitoring & Follow-up - **Before Treatment**: Evaluate for prostate cancer. Rule out other conditions causing similar symptoms. - **During Treatment**: Monitor for orthostatic hypotension symptoms, especially after dose initiation or titration. - **Clinical Signs**: Watch for dizziness, lightheadedness, syncope. ## Clinical Pearls - 💡 **Tip 1**: Advise patients to take tamsulosin **30 minutes after the same meal each day** for optimal absorption and consistent effects. - 💡 **Tip 2**: Counsel patients about the risk of **orthostatic hypotension**, especially with the first dose or dose escalation. Advise to change positions slowly. - 💡 **Tip 3**: Inform male patients about the potential for **retrograde ejaculation** (ejaculate enters the bladder), which is generally harmless but can be alarming. - 💡 **Tip 4**: Patients undergoing cataract or glaucoma surgery should inform their ophthalmologist about tamsulosin use due to the risk of **Intraoperative Floppy Iris Syndrome (IFIS)**. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.